Skip to main content
Top
Published in: Clinical Journal of Gastroenterology 4/2016

01-08-2016 | Case Report

Cholangiolocellular carcinoma with rapid progression initially showing abnormally elevated serum alfa-fetoprotein

Authors: Tomoaki Yoh, Tatsushi Kato, Yoshiaki Hirohata, Yuya Nakamura, Hiroyuki Nakayama, Ryuji Okamura

Published in: Clinical Journal of Gastroenterology | Issue 4/2016

Login to get access

Abstract

Cholangiolocellular carcinoma (CoCC) is a rare malignant liver tumor derived from hepatic progenitor cells, which exist in the canals of Hering. We encountered a case of CoCC with an extremely poor clinical course, initially showing abnormally elevated serum alfa-fetoprotein (AFP). A 72-year-old male presented with a liver tumor and abnormally elevated serum AFP levels (16,399 ng/ml). We preoperatively diagnosed hepatocellular carcinoma and performed extended right hepatectomy, after which the serum AFP levels remarkably decreased to 97 ng/ml. Postoperatively, the disease was pathologically diagnosed as CoCC. Furthermore, immunohistochemical pathological findings were alcian blue negative, cytokeratin (CK) 7 partially positive, CK19 positive, hepatocyte paraffin-1 negative, membranous negative for epithelial membrane antigen, and AFP negative. Fifty-five days later, intra- and extrahepatic recurrence developed, and the patient died 65 days after surgery. Although CoCCs show favorable outcomes, these characteristics of our case were not previously reported. It is necessary to accumulate more information on CoCC.
Literature
1.
2.
go back to reference Shiota K, Taguchi J, Nakashima O, et al. Clinicopathologic study on cholangiolocellular carcinoma. Oncol Rep. 2001;8:263–8.PubMed Shiota K, Taguchi J, Nakashima O, et al. Clinicopathologic study on cholangiolocellular carcinoma. Oncol Rep. 2001;8:263–8.PubMed
3.
go back to reference Kozaka K, Sasaki M, Fujii T, et al. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: ‘‘bile ductular carcinoma’’. Histopathology. 2007;51:390–400.CrossRefPubMed Kozaka K, Sasaki M, Fujii T, et al. A subgroup of intrahepatic cholangiocarcinoma with an infiltrating replacement growth pattern and a resemblance to reactive proliferating bile ductules: ‘‘bile ductular carcinoma’’. Histopathology. 2007;51:390–400.CrossRefPubMed
4.
go back to reference Komuta M, Spee B, Vander Borght S, et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology. 2008;4:1544–56.CrossRef Komuta M, Spee B, Vander Borght S, et al. Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin. Hepatology. 2008;4:1544–56.CrossRef
5.
go back to reference Ariizumi S, Kotera Y, Katagiri S, et al. Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy. Ann Surg Oncol. 2014;21:S451–8.CrossRefPubMed Ariizumi S, Kotera Y, Katagiri S, et al. Long-term survival of patients with cholangiolocellular carcinoma after curative hepatectomy. Ann Surg Oncol. 2014;21:S451–8.CrossRefPubMed
6.
go back to reference Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713–24.CrossRefPubMed Rahbari NN, Garden OJ, Padbury R, et al. Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). Surgery. 2011;149:713–24.CrossRefPubMed
7.
go back to reference DabevaMD S. Activation, proliferation, anddifferentiationof progenitor cells into hepatocytes in the d-galactosamine model of liver regeneration. Am J Pathol. 1993;143:1606–20. DabevaMD S. Activation, proliferation, anddifferentiationof progenitor cells into hepatocytes in the d-galactosamine model of liver regeneration. Am J Pathol. 1993;143:1606–20.
8.
go back to reference Kadono M, Kimura K, Imamura J, et al. A case of a large cholangiolocellular carcinoma. Clin J Gastroenterol. 2011;4:340–6.CrossRefPubMed Kadono M, Kimura K, Imamura J, et al. A case of a large cholangiolocellular carcinoma. Clin J Gastroenterol. 2011;4:340–6.CrossRefPubMed
Metadata
Title
Cholangiolocellular carcinoma with rapid progression initially showing abnormally elevated serum alfa-fetoprotein
Authors
Tomoaki Yoh
Tatsushi Kato
Yoshiaki Hirohata
Yuya Nakamura
Hiroyuki Nakayama
Ryuji Okamura
Publication date
01-08-2016
Publisher
Springer Japan
Published in
Clinical Journal of Gastroenterology / Issue 4/2016
Print ISSN: 1865-7257
Electronic ISSN: 1865-7265
DOI
https://doi.org/10.1007/s12328-016-0667-2

Other articles of this Issue 4/2016

Clinical Journal of Gastroenterology 4/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.